| Detected | Trial | Change |
|---|---|---|
| 2026-07-31 | NCT06947460 CD19-BCMA CART Cell Therapy for Refractory SLE-LN, SSc, and pSS-PAH |
Primary endpoint(s) modified |
| 2026-07-31 | NCT06947460 CD19-BCMA CART Cell Therapy for Refractory SLE-LN, SSc, and pSS-PAH |
date change Primary completion pushed: 2026-07-01 -> 2026-07-31 |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT07014540 | A Irinotecan Liposome Trial of in Advanced Neuroendocrine Carcinoma | Neuroendocrine Carcinomas (NEC) | Not Yet Recruiting |
| Phase 2 | |||
| NCT06433609 | Study of ADCs Combined With Adebrelimab in HER2-negative Advanced Breast Cancer | Advanced Breast Cancer | Recruiting |
| NCT06951243 | A Trial of MHB088C in Advanced Extrapulmonary Neuroendocrine Cancer | Advanced Extrapulmonary Neuroendocrine Cancer | Not Yet Recruiting |
| NCT07520357 | A Phase II Clinical Study of SHR-A1904 Monotherapy in Second-Line or Later Treatment of… | Advanced Neuroendocrine Carcinoma | Not Yet Recruiting |
| NCT07688291 | A Phase II Study of PD-1/IL-2α-bias Bispecific Antibody Fusion Protein Monotherapy in… | Esophageal Squamous Carcinoma Cell | Not Yet Recruiting |
| Phase 1/2 | |||
| NCT06925464 | CD7 CAR T-Cell Therapy for r/r T-cell Lymphomas | T-Cell Non-Hodgkin Lymphoma | Recruiting |
| NCT07022964 | CD5 CAR T-Cell Therapy for r/r T-cell Lymphomas | T-Cell Non-Hodgkin Lymphoma | Recruiting |
| NCT06316427 | Autologous and Donor-derived CD7 CAR-T Therapy in Refractory or Relapsed T-cell… | T-cell Acute Lymphoblastic Leukemia | Recruiting |
| NCT07070323 | A Multicenter, Open-Label, Non-Randomized, Single-Arm Clinical Study of Nanobody CD5-CAR… | T-Cell Acute Lymphocytic Leukemia | Recruiting |
| NCT06947473 | Umbilical Cord Blood CD19-BCMA CART Cell Therapy for SLE-LN, SSc, andpSS PAH. | Refractory Lupus Nephritis | Recruiting |
| NCT06316856 | CD5 Chimeric Antigen Receptor (CAR) T Cells in Subjects With Relapsed or Refractory… | T-Cell Acute Lymphocytic Leukemia | Recruiting |
| NCT06585514 | Anti-CD19 Chimeric Antigen Receptor T Cells for Refractory Systemic Lupus Erythematosus | Systemic Lupus Erythematosus (SLE) | Recruiting |
| NCT06688799 | Anti-CD19 Chimeric Antigen Receptor T Cells for Refractory Autoimmune Diseases | Autoimmune Diseases | Recruiting |
| NCT06947460 | CD19-BCMA CART Cell Therapy for Refractory SLE-LN, SSc, and pSS-PAH | Refractory Lupus Nephritis | Recruiting |
| Phase 1 | |||
| NCT06980597 | A Study of OL-108 in Relapsed/Refractory Autoimmune Diseases | Systemic Lupus Erythematosus (SLE) | Recruiting |
| NCT07167537 | A Study of OL-CD19-GDT in Relapsed/ Refractory Autoimmune Diseases | Systemic Sclerosis (SSc) | Recruiting |
| NCT07003555 | Dual-target BCMA-CD19 CAR-T Cell Therapy for RR/MM With Extramedullary Infiltration | Relapsed or Refractory Multiple Myeloma (RRMM) | Recruiting |
| NCT07003568 | Dual-target BCMA-GPRC5D CAR-T Cell Therapy for RR/MM With Extramedullary Infiltration | Relapsed or Refractory Multiple Myeloma (RRMM) | Recruiting |
| NCT07329894 | Safety, Tolerance and Preliminary Efficacy of XH001 Injection Combined With Neoantigen… | Gastrointestinal Cancer | Recruiting |
| NCT06326008 | Safety, Tolerability, and Pharmacokinetics of Donor-derived CD19 CAR Therapy Bridged… | B-cell Acute Lymphoblastic Leukemia | Recruiting |
| NCT06822881 | CT1190B in the Treatment of Patients With Moderate to Severe Refractory Systemic Lupus… | Systemic Lupus Erythematosus (SLE) | Recruiting |
| NCT06326021 | Optimised CD33 (FL-33) CAR T Therapy for Refractory/Relapsed Acute Myeloid Leukaemia | Refractory/Relapsed Acute Myeloid Leukaemia | Recruiting |
| Early Phase 1 | |||
| NCT07093411 | Targeting CD19/CD20 Dual-targeted Cell in Patients With Relapsed/Refractory B-cell… | B-cell Non-Hodgkin Lymphoma Recurrent B-cell Non-Hodgkin Lymphoma Refractory | Recruiting |
| NCT07242417 | TC-G203 for Patients With GPC3-Positive Advanced Solid Tumors | Solid Cancer | Recruiting |
| NCT06890494 | Clinical Study on the Safety and Efficacy of BiTE-EV in Relapsed/Refractory Acute B-Cell… | Leukemia | Recruiting |